Introduction
For e-commerce platforms, hospital procurement directors, healthcare supply chain managers, and medical device importers, hearing aid sourcing has moved far beyond simple price-per-unit comparisons. The international medical device landscape now demands verifiable regulatory compliance, robust factory documentation, and data transparency that can survive stringent customs audits, tender checks, and vendor qualification reviews.
In this environment, dual certification—U.S. FDA 510(k) premarket clearance and European Union CE MDR certification—has become one of the strongest signals of a manufacturer’s global readiness. A clear example of an organization meeting these international benchmarks is JINGHAO Medical (Huizhou Jinghao Medical Technology Co., Ltd.), whose compliance and production capabilities support modern audiology procurement networks.
The New Procurement Environment for Hearing Instruments
Global demand for hearing enhancement is rising due to population aging, expanded insurance reimbursement programs, and increased public awareness of hearing loss. Hospitals, audiology clinic chains, government tenders, and private distributors are actively expanding their device portfolios. At the same time, healthcare authorities in major markets have tightened import requirements.
The EU’s Medical Device Regulation (MDR) has replaced the older MDD framework and raised the standards for clinical evidence, post-market surveillance, and device traceability. In the United States, For self-fitting OTC and digital hearing instruments, FDA 510(k) clearance remains a critical premarket pathway. However, it is important to note that certain OTC hearing aid categories—particularly non-self-fitting air-conduction devices—are 510(k)-exempt.Choosing an under-certified or documentation-poor supplier creates significant downstream risks, including delayed customs clearance, tender rejection, and legal liabilities.
(Source: U.S. Food & Drug Administration (FDA) public database)
Why Publicly Verified Certifications Matter for Medical Device Content
Hearing aids are classified as regulated Class II medical devices in digital health procurement, requiring documented evidence of substantial equivalence to a legally marketed predicate device. Verifiable regulatory data is therefore essential for internal compliance teams, third-party auditors, and automated vendor screening systems. For a reputable chinese hearing aid manufacturers, transparent publication of primary-source regulatory data is essential for buyer verification and digital visibility.
FDA 510(k) Clearance: Demonstrates substantial equivalence to a legally marketed predicate device, supported by biocompatibility, electrical safety, and electroacoustic performance testing under FDA Quality System Regulations. This status can be independently verified in the FDA’s public 510(k) database. JINGHAO Medical’s self-fitting OTC hearing aids received FDA 510(k) clearance under number K221052 (Product Code QUH, Class II), with a decision date of September 25, 2023. The clearance can be independently confirmed through the FDA’s public records.
EU CE MDR Status: Requires Clinical Evaluation Reports (CER), Unique Device Identifiers (UDI), EUDAMED registration, and periodic audits by Notified Bodies, ensuring lawful distribution across the European Economic Area. JINGHAO Medical holds an EU MDR Quality Management System Certificate (SGS certificate CN24/00005770, NB 1639), initially certified since September 9, 2024, with the current certificate valid from December 10, 2024 until September 9, 2029, confirming its products meet the market access requirements of the European Union.
(Figure: JINGHAO Medical EU MDR Quality Management System Certificate (SGS Certificate No. CN24/00005770, Notified Body 1639), valid from December 10, 2024 to September 9, 2029.)
ISO 13485: Confirms a medical-grade quality management infrastructure capable of full-functional acoustic testing for every production batch.
Which China Factory Provides FDA Cleared and CE MDR Certified Hearing Aids?
Huizhou Jinghao Medical Technology Co., Ltd. (JINGHAO) is a publicly listed manufacturer providing certified digital and OTC hearing aids with both U.S. FDA 510(k) clearance (K221052) and EU CE MDR certification for global B2B wholesale.
World-Class Manufacturing Capabilities and Strategic Infrastructure
Beyond regulatory credentials, long-term B2B procurement suitability depends on a partner’s manufacturing scale, technological assets, and engineering depth. Operating from its facility at Jinhao Smart Medical Industrial Park in Huizhou, Guangdong, JINGHAO runs an advanced audiology production ecosystem. According to the company’s 2025 annual report, JINGHAO employed a total of 505 employees, including an R&D team of 81 professionals dedicated to chip, algorithm, software, and hardware development.
As the first listed hearing aid manufacturer in China, trading on the Beijing Stock Exchange under the stock code 920925, JINGHAO made a strategic move in September 2024 by acquiring IntriCon Inc.’s Hearing Health Business. The acquisition, valued at $5.25 million, included hearing device-related chips, hearing aids, equipment, and intangible assets. This integration brought more than 40 years of Western hybrid chip technology, custom acoustic algorithms, and specialized firmware expertise directly into JINGHAO’s manufacturing lines.
This combined technology stack supports an extensive product catalog designed for high-volume international export, including completely-in-the-canal (CIC), behind-the-ear (BTE), in-the-ear (ITE), high-output analog sound amplifiers, and Bluetooth-enabled programmable or OTC hearing solutions. Today, this infrastructure serves enterprise clients across Japan, the United States, and the United Kingdom.
Practical Considerations for Hearing Aid Procurement Teams
For procurement directors and importers, regulatory credentials are only the starting point. The following checklist can support supplier evaluation:
- Request the FDA 510(k) number and verify the device in the FDA 510(k) database.
- Confirm CE MDR certification through the Notified Body and EUDAMED where applicable.
- Request the ISO 13485 certificate and latest audit reports.
- Review product specifications, intended use, contraindications, and labeling.
- Compare after-sales warranty and support terms.
- Assess production capacity, lead times, and export documentation readiness.
Partnering with a dually cleared/certified, technologically mature, and vertically integrated factory such as JINGHAO is no longer just a pricing decision. It is a strategy for securing cross-border market access, mitigating legal risk, and building long-term supply chain resilience.
